PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses

Journal of Cellular and Molecular Medicine - Tập 15 Số 8 - Trang 1769-1777 - 2011
Suresh S. Palaniyandi1,2, Julio Cesar Batista Ferreira1,3,2, Patrı́cia C. Brum3, Daria Mochly‐Rosen1
1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA
2these authors contributed equally to the study
3School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

Churchill, 2008, PKC isozymes in chronic cardiac disease: possible therapeutic targets, Annu Rev Pharmacol Toxicol, 48, 569, 10.1146/annurev.pharmtox.48.121806.154902

Palaniyandi, 2009, Protein kinase C in heart failure: a therapeutic target, Cardiovasc Res, 82, 229, 10.1093/cvr/cvp001

Hambleton, 2006, Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure, Circulation, 114, 574, 10.1161/CIRCULATIONAHA.105.592550

Inagaki, 2003, Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo, Circulation, 108, 2304, 10.1161/01.CIR.0000101682.24138.36

Inagaki, 2002, Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta, J Mol Cell Cardiol, 34, 1377, 10.1006/jmcc.2002.2089

Inagaki, 2008, Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure, Hypertension, 51, 1565, 10.1161/HYPERTENSIONAHA.107.109637

Braun, 2003, Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors, J Mol Cell Cardiol, 35, 895, 10.1016/S0022-2828(03)00142-1

Bowling, 1999, Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart, Circulation, 99, 384, 10.1161/01.CIR.99.3.384

Sabri, 2003, Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure, Mol Cell Biochem, 251, 97, 10.1023/A:1025490017780

Simonis, 2007, Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy, Mol Cell Biochem, 305, 103, 10.1007/s11010-007-9533-3

Wakasaki, 1997, Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy, Proc Natl Acad Sci U S A, 94, 9320, 10.1073/pnas.94.17.9320

Piacentini, 2000, Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C, J Mol Cell Cardiol, 32, 565, 10.1006/jmcc.2000.1109

Baines, 2002, Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection, Circ Res, 90, 390, 10.1161/01.RES.0000012702.90501.8D

Sentex, 2006, Expression of protein kinase C isoforms in cardiac hypertrophy and heart failure due to volume overload, Can J Physiol Pharmacol, 84, 227, 10.1139/y05-120

Bates, 2008, Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction, Circulation, 117, 886, 10.1161/CIRCULATIONAHA.107.759167

Takano, 2003, Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies, Intern Med, 42, 465, 10.2169/internalmedicine.42.465

Cohn, 1995, Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition, Circulation, 91, 2504, 10.1161/01.CIR.91.10.2504

Pfeffer, 1979, Myocardial infarct size and ventricular function in rats, Circ Res, 44, 503, 10.1161/01.RES.44.4.503

Oliveira, 2009, Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice, J Physiol, 587, 3899, 10.1113/jphysiol.2009.173948

Pereira, 2009, Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice, Eur J Appl Physiol, 105, 843, 10.1007/s00421-008-0967-4

Palaniyandi, 2004, Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats, Eur J Immunol, 34, 3508, 10.1002/eji.200425147

Stebbins, 2001, Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C, J Biol Chem, 276, 29644, 10.1074/jbc.M101044200

Moustakas, 2001, Smad regulation in TGF-beta signal transduction, J Cell Sci, 114, 4359, 10.1242/jcs.114.24.4359

Chen, 2008, Cytokines and acute heart failure, Crit Care Med, 36, S9, 10.1097/01.CCM.0000297160.48694.90

Niebauer, 2000, Inflammatory mediators in heart failure, Int J Cardiol, 72, 209, 10.1016/S0167-5273(99)00190-4

Palaniyandi Selvaraj, 2005, Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy, Biol Pharm Bull, 28, 2128, 10.1248/bpb.28.2128

Bowman, 1997, Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates, J Clin Invest, 100, 2189, 10.1172/JCI119755

Roman, 2001, PKC-beta is not necessary for cardiac hypertrophy, Am J Physiol Heart Circ Physiol, 280, H2264, 10.1152/ajpheart.2001.280.5.H2264

Boyle, 2005, Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction, J Mol Cell Cardiol, 39, 213, 10.1016/j.yjmcc.2005.03.008

Nikodemova, 2007, Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII, J Biol Chem, 282, 15208, 10.1074/jbc.M611907200

Devaraj, 2005, Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}, Diabetes, 54, 85, 10.2337/diabetes.54.1.85

Lewin, 1996, Aggregation of the Fc epsilon RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding-activity: the dependence on protein kinase C-beta, J Biol Chem, 271, 1514, 10.1074/jbc.271.3.1514

Kawakami, 2004, Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion, J Biol Chem, 279, 47720, 10.1074/jbc.M408797200

Nechushtan, 2000, Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta, Blood, 95, 1752, 10.1182/blood.V95.5.1752.005k18_1752_1757

Ludowyke, 2006, Phosphorylation of nonmuscle myosin heavy chain IIA on Ser1917 is mediated by protein kinase C beta II and coincides with the onset of stimulated degranulation of RBL-2H3 mast cells, J Immunol, 177, 1492, 10.4049/jimmunol.177.3.1492

Kraft, 1983, Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane, Nature, 301, 621, 10.1038/301621a0